Home › NDC Lookup › RxCUI directory › RxCUI 2697167

Aripiprazole 5 MG Oral Film [Opipza] — RxCUI 2697167

RxNorm drug concept · Semantic branded drug
RxCUI 2697167 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2697167
Official nameAripiprazole 5 MG Oral Film [Opipza]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOpipza 5 MG Oral Film
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)96 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aripiprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Not at all — aripiprazole actually has several approved uses. It's prescribed for schizophrenia, manic or mixed episodes of Bipolar I Disorder, and as an add-on to antidepressants...
  • What exactly is aripiprazole used for — is it just for schizophrenia?
  • It typically takes up to two weeks for aripiprazole to build up to stable levels in your body, so don't be discouraged if you don't feel a difference right away. For some condition...
  • How long does it take before I notice it working?
📖 Read our full Aripiprazole guide →

🕸️ Concept Web — How Aripiprazole 5 MG Oral Film [Opipza] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aripiprazole 5 MG Oral Film [Opipza] RxCUI 2697167

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Aripiprazole 89013
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Opipza 2697159
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aripiprazole Oral Film 2697157
    • Aripiprazole Oral Film Product 2697156
    • Aripiprazole Oral Product 1158261
    • Aripiprazole Oral Film [Opipza] 2697163
    • Opipza Oral Film Product 2697162
    • Opipza Oral Product 2697161
    • Oral Film 2269575
    • Oral Film Product 2269502
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aripiprazole 5 MG Oral Film SCD · 2697165
  • Aripiprazole 5 MG SCDC · 402368
  • Aripiprazole Oral Film SCDF · 2697157
  • Aripiprazole Oral Film Product SCDG · 2697156
  • Aripiprazole Oral Product SCDG · 1158261

Brand-Name Concepts

  • Aripiprazole 5 MG [Opipza] SBDC · 2697166
  • Aripiprazole Oral Film [Opipza] SBDF · 2697163
  • Opipza Oral Film Product SBDG · 2697162
  • Opipza Oral Product SBDG · 2697161
  • Opipza BN · 2697159

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 2697167 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
15370-0401-30 30 POUCH in 1 CARTON (15370-401-30) / 1 FILM, SOLUBLE in 1... OPIPZA Carwin Pharmaceutical Associates, LLC 2024-11-01
15370-0401-99 2 POUCH in 1 CARTON (15370-401-99) / 1 FILM, SOLUBLE in 1 P... OPIPZA Carwin Pharmaceutical Associates, LLC 2025-01-28
15370-0402-30 30 POUCH in 1 CARTON (15370-402-30) / 1 FILM, SOLUBLE in 1... OPIPZA Carwin Pharmaceutical Associates, LLC 2024-11-01
15370-0402-99 2 POUCH in 1 CARTON (15370-402-99) / 1 FILM, SOLUBLE in 1 P... OPIPZA Carwin Pharmaceutical Associates, LLC 2025-01-28
15370-0403-30 30 POUCH in 1 CARTON (15370-403-30) / 1 FILM, SOLUBLE in 1... OPIPZA Carwin Pharmaceutical Associates, LLC 2024-11-01
Observed labelers: Carwin Pharmaceutical Associates, LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.